| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $30.8M | +149.2% |
| SG&A Expense | $15.4M | -64.1% |
| Operating Income | -$46.2M | +29.5% |
| Interest Expense | $1.4M | -46.6% |
| Pre-tax Income | -$43.4M | +26.1% |
| Income Tax | $0 | — |
| Net Income | -$43.4M | +26.1% |
| EPS (Basic) | -$2.85 | +75.7% |
| EPS (Diluted) | -$2.85 | +75.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $98.1M | -17.1% |
| Short-term Investments | $19.9M | — |
| Current Assets | $118.8M | +0.2% |
| Total Assets | $121.7M | +2.7% |
| Current Liabilities | $9.7M | +85.4% |
| Total Liabilities | $42.9M | +719.3% |
| Stockholders' Equity | $78.8M | -30.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$38.4M | +43.3% |
| Capital Expenditures | $200K | — |
| Investing Cash Flow | -$19.7M | -120.8% |
| Financing Cash Flow | $155.0M | — |
| Free Cash Flow | -$38.6M | — |